In Brief: Biopool
This article was originally published in The Gray Sheet
Executive Summary
Biopool: Receives 510(k) clearance to market its Sure drugs-of-abuse control products for use in monitoring the accuracy of drugs-of-abuse tests in clinical and forensic laboratories. Sure is the first test to employ "a completely synthetic urine matrix, which simulates the composition and physical characteristics of human urine but without the normal human biohazards," the firm explains...